单纯性肾囊肿与腹主动脉瘤患者 24 个月预后的关系：一项回顾性队列研究

行 杨(承德医学院附属医院，中国)
玉林 肖(承德医学院附属医院，中国)
振生 李(承德医学院附属医院，中国)
弘 张(承德医学院附属医院，中国)

摘要

目的：本研究的目的是探索SRC是否影响AAA患者血管内动脉瘤修复(EVAR)后的预后。方法：本研究为回顾性队列研究。入选2000年1月至2022年3月在承德医学院附属医院接受EVAR的AAA患者，根据是否合并SRC，分为SRC组和无SRC组。随访记录患者预后期间不良事件。采用多因素Cox回归分析腹主动脉不良事件的危险因素。采用Kaplan-Meier法分析SRC组及无SRC组生存曲线。结果：多变量分析表明，SRC患者（HR 3.211，95% CI 1.241-8.308, p=0.016），BMI（HR 1.246，CI95%1.021-1.522，P=0.031）为AAA患者EVAR术后并发症出现的危险因素。结论：SRC的存在对行EVAR的AAA患者24个月不良预后的发生具有重要的价值。

关键词

单纯性肾囊肿；腹主动脉瘤；EVAR

参考

R.L. Dalman, M.M. Tedesco, J. Myers, C.A. Taylor, AAA disease: HR95CIP术后转氨酶，median （IQR）1.0081.001-1.0170.06出院用药，n （%） ACEI/ARB，n （%）1.6150.591-4.4150.35CCB，n （%）0.9960.335-2.9620.995β 受体阻滞剂，n （%）1.6040.622-4.1350.329利尿剂，n （%）1.6010.586-4.3710.359他汀类，n （%）2.2290.751-6.6240.149续表4mechanism, stratification, and treatment[J]. Ann N Y Acad Sci, 1085 (2006)92-109.

M.J. Davies, Aortic aneurysm formation: lessons from human studies and experimental models[J]. Circulation, 98 (1998) 193- 195.

B.J. Toghill, A. Saratzis, M.J. Bown, Abdominal aortic aneurysm - an independent disease to atherosclerosis[J]. Cardiovasc Pathol, 27 (2017) 71- 75.

F.A. Lederle, J.A. Freischlag, T.C. Kyriakides, F.T. Padberg, Jr., J.S. Matsumura, T.R. Kohler, P.H. Lin, J.M. Jean- Claude, D.F. Cikrit, K.M. Swanson[J]. P.N. Peduzzi, Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial, Jama, 302 (2009) 1535- 1542.

R. Patel,M.J.Sweeting,J.T.Powell,R.M.Greenhalgh,Endovascular versus open repair of abdominal aortic aneurysm in 15- years’follow- up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial[J]. Lancet, 388 (2016) 2366-

M.L. Schermerhorn, D.B. Buck, A.J. O’Malley, T. Curran, J.C. McCallum, J. Darling, B.E. Landon, Long- Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population[J]. N Engl J Med, 373 (2015) 328- 338.

K.D. Dansey, R.R.B. Varkevisser, N.J. Swerdlow, C. Li, L. de Guerre, P. Liang, C. Marcaccio, T.F.X. O’Donnell, B.J. Carroll, M.L[J]. Schermerhorn, Epidemiology of endovascular and open repair for abdominal aortic aneurysms in the United States from 2004 to 2015 and implications for screening, J Vasc Surg, 74 (2021) 414- 424.

A .Dua, S. Kuy, C.J. Lee, G.R. Upchurch, Jr., S.S. Desai, Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010[J]. Vasc Surg, 59 (2014) 1512- 1517.

J.C. Parodi, J.C. Palmaz, H.D. Barone, Transfemoral intraluminal graft implantation for abdominal aortic aneurysms[J]. Ann Vasc Surg, 5 (1991) 491- 499.

E.L. Chaikof, J.D. Blankensteijn, P.L. Harris, G.H. White, C.K. Zarins, V.M. Bernhard, J.S. Matsumura, J. May, F.J. Veith, M.F. Fillinger, R.B. Rutherford, K.C. Kent, Reporting standards for endovascular aortic aneurysm repair[J]. Vasc Surg, 35 (2002) 1048- 1060.

T. Ito, N. Kawaharada, Y. Kurimoto, A. Watanabe, K.Tachibana, R. Harada, T. Maeda, H. Hashiguchi, M. Hashimoto, T. Higami, Renal cysts as strongest association with abdominal aortic aneurysm in elderly[J]. Ann Vasc Dis, 3 (2010) 111- 116.

Yaghoubian, C. de Virgilio, R.A. White, G. Sarkisyan, Increased incidence of renal cysts in patients with abdominal aortic aneurysms: a common pathogenesis[J]. Ann Vasc Surg, 20 (2006) 787- 791.

E.D. Dillavou, D.G. Buck, S.C. Muluk, M.S.Makaroun, Two- dimensional versus three- dimensional CT scan for aortic measurement[J]. Endovasc Ther, 10 (2003) 531- 538.

S. Horie, T. Mochizuki, S. Muto, K. Hanaoka, Y. Fukushima, I. Narita, K. Nutahara, K. Tsuchiya, K. Tsuruya, K. Kamura, S. Nishio, T. Suwabe,Y.Ubara,E. Ishimura, K. Nakanishi, K. Furukawa, K. Kimura, S. Matsuo, Evidence- based clinical practice guidelines for polycystic kidney disease 2014[J]. Clin Exp Nephrol, 20 (2016):493-509.

L.B. Gindera, K.P. Donas, G. Torsello,T.Bisdas,K.Stavroulakis, Significant CT- angiographic evidence of coexisting abdominal aortoiliac aneurysms with simple renal cysts and abdominal wall hernias[J]. Minerva Chir, 70 (2015) 409- 416.

R.J. Simms, A.C. Ong, How simple are ‘simple renal cysts[J]. Nephrol Dial Transplant, 29 Suppl 4 (2014) iv106- 112.

J. Golledge, Abdominal aortic aneurysm: update on pathogenesis and medical treatments[J]. Nat Rev Cardiol, 16 (2019) 225- 242.

M.A. Bailey, K.J. Griffin, A.L.Windle,S.W.Lines,D.J.Scott,Cysts and swellings: a systematic review of the association between polycystic kidney disease and abdominal aortic aneurysm[J]. Ann Vasc Surg, 27 (2013) 123- 128.

H. Takagi, T. Umemoto, Simple renal cyst and abdominal aortic aneurysm[J]. Vasc Surg, 63 (2016) 254- 259.e251.

S.H. Tsai, L.A. Hsu, H.Y. Tsai, Y.H. Yeh, C.Y. Lu, P.C. Chen, J.C. Wang, Y.L. Chiu, C.Y. Lin, Y.J. Hsu, Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells[J]. Faseb, 34 (2020) 9498- 9511.

G. Ailawadi, J.L. Eliason, G.R. Upchurch, Jr., Current concepts in the pathogenesis of abdominal aortic aneurysm[J]. Vasc Surg, 38 (2003) 584- 588.

N. Obermüller, N. Morente, B. Kränzlin, N. Gretz, R. Witzgall, A possible role for metalloproteinases in renal cyst development[J]. Am J Physiol Renal Physiol, 280 (2001)F540- 550.

S.W. Rabkin, The Role Matrix Metalloproteinases in the Production of Aortic Aneurysm[J]. Prog Mol Biol Transl Sci, 147 (2017) 239- 265.

R.W. Thompson,W.C. Parks, Role of matrixmetalloproteinases in abdominal aortic aneurysms[J]. Ann N Y Acad Sci, 800 (1996) 157- 174.

G.M. Longo, W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, B.T. Baxter, Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms[J]. Clin Invest, 110 (2002) 625- 632.

D.R. Lorelli, J.M. Jean- Claude C.J. Fox, J. Clyne, R.A. Cambria,G.R. Seabrook, J.B. Towne, Response of plasma matrix metalloproteinase- 9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak[J]. Vasc Surg, 35 (2002) 916- 922.

G. Maleux, L. Poorteman, A. Laenen, B. Saint- Lèbes, S. Houthoofd, I. Fourneau, H. Rousseau, Incidence, etiology, and management of type III endoleak after endovascular aortic repair[J]. Vasc Surg, 66 (2017) 1056- 1064.

E. Ng, D.R. Morris, J. Golledge, The association between plasma matrix metalloproteinase- 9 concentration and endoleak after endovascular aortic aneurysm repair: a meta- analysis[J]. Atherosclerosis, 242 (2015) 535- 542.

G. Marques- Rios, J. Oliveira- Pinto, A. Mansilha, Predictors of long- term mortalityfollowing elective endovascular repair of abdominal aortic aneurysms[J]. Int Angiol, 37 (2018) 277-285.

B.W. Starnes, C.A.Andersen, J.A. Ronsivalle, N.R.Stockmaster, P.S.Mullenix, J.D. Statler, Totally percutaneous aortic aneurysm repair: experience and prudence[J]. Vasc Surg, 43 (2006) 270- 276.

E.S. Xenos, J.A. Lyden, R.L Korosec, D.L. Davenport, Ninety- day readmission risks, rates, and costs after common vascular surgeries[J]. Am J Manag Care, 20(2014) e432- 438.

K.A. Giles, M.C. Wyers, F.B. Pomposelli, A.D. Hamdan, Y.A. Ching, M.L. Schermerhorn, The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005- 2007[J]. Vasc Surg, 52 (2010) 1471- 1477.

T. Li, Z. Lv, J.J. Jing, J. Yang, Y. Yuan, Matrix metalloproteinase family polymorphisms and the risk of aortic aneurysmal diseases: A systematic review and meta- analysis[J]. Clin Genet, 93 (2018) 15-32.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i12.22890